These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30952475)

  • 21. Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management.
    Kün-Darbois JD; Fauvel F
    Morphologie; 2021 Jun; 105(349):170-187. PubMed ID: 33281055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-resorptive therapy and MRONJ. A survey of the Italian Society of Periodontology and Implantology.
    Landi L; Oteri G; Barbato L; Discepoli N; Carrassi AM; Rigoni M; Cairo F; Cavalcanti R; Crea A; Gianserra R; Sforza NM
    Oral Dis; 2024 Oct; 30(7):4528-4537. PubMed ID: 38424699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The awareness and practice of dentists regarding medication-related osteonecrosis of the jaw and its prevention: a cross-sectional survey.
    Han AL
    BMC Oral Health; 2021 Mar; 21(1):155. PubMed ID: 33761923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is the prevalence of the medication-related osteonecrosis of the jaws underestimated, evaluation in oncological and non-oncological disease.
    Galis B; Zajko J; Hirjak D; Vanko L; Kupcova I; Jurkemik J; Gengelova P; Mikuskova K; Halmova K; Riznic M; Czako L
    Bratisl Lek Listy; 2017; 118(12):724-731. PubMed ID: 29322803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dental practitioners' and students' knowledge of medication related osteonecrosis of the jaw (MRONJ).
    Almousa MA; Alharbi GK; Alqahtani AS; Chachar Y; Alkadi L; Aboalela A
    Saudi Pharm J; 2021 Jan; 29(1):96-103. PubMed ID: 33603544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knowledge of Dental Students and Practitioners About Medication-Related Osteonecrosis of the Jaw in the Central Region of Saudi Arabia.
    Alghofaili MM; Mohsin SF; Nahari NM; Alkhalifah TS; Almazyad RK; Alsaegh MK
    Cureus; 2024 Jan; 16(1):e52165. PubMed ID: 38222989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bisphosphonates, healthcare professionals and oral health.
    Raj DV; Abuzar M; Borromeo GL
    Gerodontology; 2016 Mar; 33(1):135-43. PubMed ID: 25039439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Awareness, perceptions and attitudes toward medication-related osteonecrosis of the jaw among physicians who treat osteoporosis.
    Aljohani S
    Saudi Pharm J; 2023 Sep; 31(9):101707. PubMed ID: 37546526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Awareness of MRONJ amongst dentists.
    Wadia R
    Br Dent J; 2019 May; 226(10):794. PubMed ID: 31127227
    [No Abstract]   [Full Text] [Related]  

  • 30. Knowledge and attitudes of French dentists on bone resorption inhibitors (bisphosphonates and denosumab): A cross-sectional study.
    Arnaud MP; Talibi S; Lejeune-Cairon S
    J Stomatol Oral Maxillofac Surg; 2022 Apr; 123(2):163-170. PubMed ID: 33930600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteonecrosis of the jaws: a 14-year retrospective survey of hospital admissions.
    McGowan K; Ivanovski S; Acton C
    Aust Dent J; 2018 Jun; 63(2):202-207. PubMed ID: 29432652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knowledge and Opinions of Saudi Dentists Regarding Dental Treatment of Patients Undergoing Bisphosphonates.
    Al-Maweri SA; Alshammari MN; Alharbi AR; Bahein AA; Alhajj MN; Al-Shamiri HM; Alahmary AW; Doumani M
    Eur J Dent; 2020 Feb; 14(1):144-151. PubMed ID: 32032970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiographic Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) With Different Primary Cancers and Medication Therapies.
    Muttanahally KS; Tadinada A
    Cureus; 2023 Aug; 15(8):e42830. PubMed ID: 37664344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knowledge, Attitude, and Management of General Dentist toward Medication-related Osteonecrosis of the Jaws.
    Alqhtani NR; Almalki AK; Zuhair FA; Alenazi AA; Nabhan AB; Alqahtani M
    J Pharm Bioallied Sci; 2020 Aug; 12(Suppl 1):S151-S154. PubMed ID: 33149447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteonecrosis of the jaw in primary dental care: Recognition and referral.
    Burns M; Patel V
    Prim Dent J; 2022 Sep; 11(3):108-116. PubMed ID: 36073051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Declining Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Cancer.
    Sim IeW; Sanders KM; Borromeo GL; Seymour JF; Ebeling PR
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3887-93. PubMed ID: 26241323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knowledge, practices, and opinions of ontario dentists when treating patients receiving bisphosphonates.
    Alhussain A; Peel S; Dempster L; Clokie C; Azarpazhooh A
    J Oral Maxillofac Surg; 2015 Jun; 73(6):1095-105. PubMed ID: 25843818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opinions and attitudes of the UK's GDPs and specialists in oral surgery, oral medicine and surgical dentistry on oral cancer screening.
    Kujan O; Duxbury AJ; Glenny AM; Thakker NS; Sloan P
    Oral Dis; 2006 Mar; 12(2):194-9. PubMed ID: 16476043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.